(Press-News.org) Researchers at The Pennsylvania State University College of Medicine, led by Dr. Ian S. Zagon, have discovered that a novel biological pathway, the OGF-OGFr axis, can be modulated in human triple-negative breast cancer cells to inhibit proliferation. According to BreastCancer.org 1 in 8 women in the U.S. will develop invasive breast cancer and more than 39,000 deaths occur annually. Approximately 15 to 20% of all breast cancers are designated as triple-negative meaning that the cancer cells lack estrogen and progesterone receptors, and do not overexpress human epidermal growth factor receptor (HER-2), thereby limiting responsiveness to approved therapy.
In the June 2013 issue of Experimental Biology and Medicine, Zagon and colleagues demonstrate that exposure of human breast cancer cell lines to OGF in vitro repressed growth within 24 hr in a receptor-mediated and reversible manner. Treatment with low dosages of the opioid antagonist naltrexone (LDN) provoked a compensatory elevation in endogenous opioids (i.e., OGF) and receptors that interact for 18-20 hr daily following receptor blockade to elicit a robust inhibition of cell proliferation. Because OGF is an endogenous neuropeptide, there are minimal or no side effects. The mechanism of action for OGF is upregulation of the p21 cyclin-dependent inhibitory kinase pathway that delays passage through the cell cycle. OGF also confers some level of protection against paclitaxel treatment, a standard breast cancer therapy. A dosage of 10-8 M paclitaxel given alone caused marked apoptosis, but resulted in 60% less cell death when given in the presence of OGF. In patients, paclitaxel often is accompanied by side effects that reduce compliance.
This discovery provides preclinical evidence for a novel, safe, and effective therapy for breast cancer patients, especially for those with limited therapeutic approaches other than surgery. "What is exciting about our findings", said Dr. Zagon, senior author and Distinguished University Professor, "is that women with triple-negative breast cancer have few options because their tumors lack the necessary hormonal receptors. Data from these studies open new doors for treatment of this population of women." Moreover, the OGF-OGFr axis is present in all types of breast cancer cells suggesting that this pathway provides additional avenues for treatment of this commonly diagnosed cancer.
Dr. Steven R. Goodman, Editor-in-Chief of Experimental Biology and Medicine, said "Zagon and colleagues have extended their 3 decade-long research on the OGF-OGFr axis to another aggressive cancer, and show that the biotherapy OGF (or LDN to stimulate OGF) is an effective alternative for treatment of breast cancer".
###
Experimental Biology and Medicine is a journal dedicated to the publication of multidisciplinary and interdisciplinary research in the biomedical sciences. The journal was first established in 1903. Experimental Biology and Medicine is the journal of the Society of Experimental Biology and Medicine. To learn about the benefits of society membership visit http://www.sebm.org. If you are interested in publishing in the journal please visit http://ebm.sagepub.com/.
Successful treatment of triple negative breast cancer by modulation of the OGF-OGFr axis
2013-08-09
ELSE PRESS RELEASES FROM THIS DATE:
New insights into the polymer mystique for conducting charges
2013-08-09
WASHINGTON D.C. August 9, 2013 -- For most of us, a modern lifestyle without polymers is unthinkable…if only we knew what they were. The ordinary hardware-store terms we use for them include "plastics, polyethylene, epoxy resins, paints, adhesives, rubber" -- without ever recognizing the physical and chemical structures shared by this highly varied -- and talented -- family of engineering materials.
Polymers increasingly form key components of electronic devices, too -- and with its ever-escalating pursuit of high efficiency and low cost, the electronics industry prizes ...
Cells eat themselves into shape
2013-08-09
The process cells use to 'swallow' up nutrients, hormones and other signals from their environment – called endocytosis – can play a crucial role in shaping the cells themselves, scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, have found. The study, published today in Nature Communications, could help explain how the cells on your skin become different from those that line your stomach or intestine.
"We're the first to show that endocytosis really drives changes in cell shape by directly remodelling the cell membrane," says Stefano ...
The 'genetics of sand' may shed new light on evolutionary process over millions of years
2013-08-09
An evolutionary ecologist at the University of Southampton, is using 'grains of sand' to understand more about the process of evolution. Dr Thomas Ezard is using the fossils of microscopic aquatic creatures called planktonic foraminifera, often less than a millimetre in size, which can be found in all of the world's oceans. The remains of their shells now resemble grains of sand to the naked eye and date back hundreds of millions of years.
A new paper by Dr Ezard, published today (9 August 2013) in the journal Methods in Ecology & Evolution, opens the debate on the best ...
How to achieve a well-balanced gut
2013-08-09
Creating an environment that nurtures the trillions of beneficial microbes in our gut and, at the same time, protects us against invasion by food-borne pathogens is a challenge. A study published on August 8 in PLOS Pathogens reveals the role of a key player in this balancing act.
SIGIRR is a protein present at the surface of the cells that line the gut that dampens the innate (non-specific) immune response of these cells to bacteria. The new study, led by Xiaoxia Li (from the Lerner Research Institute in Cleveland, USA) and Bruce Vallance (from BC's Childrens' Hospital ...
Dialysis patients may live longer if their kidney specialist sees fewer patients
2013-08-09
Nephrologists whose dialysis patients had the best survival over six years had a significantly lower patient caseload than nephrologists whose patients had the worst survival.
For every additional 50 patients cared for by a nephrologist, patients had a 2% higher risk of dying within six years.
Worldwide, more than 1.5 million people are treated with hemodialysis.
Washington, DC (August 8, 2013) — Dialysis patients receiving treatment from kidney specialists with a higher patient caseload have a greater risk of dying prematurely than those receiving care from specialists ...
JILA researchers discover atomic clock can simulate quantum magnetism
2013-08-09
Researchers at JILA have for the first time used an atomic clock as a quantum simulator, mimicking the behavior of a different, more complex quantum system.*
Atomic clocks now join a growing list of physical systems that can be used for modeling and perhaps eventually explaining the quantum mechanical behavior of exotic materials such as high-temperature superconductors, which conduct electricity without resistance. All but the smallest, most trivial quantum systems are too complicated to simulate on classical computers, hence the interest in quantum simulators. Sharing ...
Telemedicine consultations significantly improve pediatric care in rural emergency rooms
2013-08-09
Telemedicine consultations with pediatric critical-care medicine physicians significantly improve the quality of care for seriously ill and injured children treated in remote rural emergency rooms, where pediatricians and pediatric specialists are scarce, a study by researchers at UC Davis Children's Hospital has found.
The study also found that rural emergency room physicians are more likely to adjust their pediatric patients' diagnoses and course of treatment after a live, interactive videoconference with a specialist. Parents' satisfaction and perception of the quality ...
Study reveals role of 'peacekeeper' in the gut
2013-08-09
A new study has shone a spotlight on the peacekeeping mechanisms in our intestines.
A protein, called SIGIRR, is produced by the cells that line the intestines. It supresses the cells' immune response to bacteria.
"We expected that when SIGIRR was removed, our intestines would trigger a stronger immune response to a gut infection, affording us more protection against the infection," says Prof. Bruce Vallance, an associate professor in UBC's Dept. of Pediatrics and a scientist at the Child & Family Research Institute at BC Children's Hospital. "Instead, the stronger ...
Autism affects different parts of the brain in women and men
2013-08-09
Autism affects different parts of the brain in females with autism than males with autism, a new study reveals. The research is published today in the journal Brain as an open-access article.
Scientists at the Autism Research Centre at the University of Cambridge used magnetic resonance imaging to examine whether autism affects the brain of males and females in a similar or different way. They found that the anatomy of the brain of someone with autism substantially depends on whether an individual is male or female, with brain areas that were atypical in adult females ...
Muscle health depends on sugar superstructure
2013-08-09
For many inherited diseases, such as cystic fibrosis or Huntington disease, the disease-causing genetic mutation damages or removes a protein that has an essential role in the body. This protein defect is the root cause of the disease symptoms.
However, for a group of muscular dystrophies known collectively as congenital muscular dystrophies (CMDs), the sequence of the protein that is central to normal function is typically unaffected. Instead, the defects lie in processing proteins—ones that are responsible for modifying the central protein by adding sugar chains (glycans). ...